NIAGEN BIOSCIENCE, INC. Contractual Obligation, to be Paid, Year One
NIAGEN BIOSCIENCE, INC. (NAGE) had Contractual Obligation, to be Paid, Year One of GBP 35.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInNextTwelveMonths · last filed 2026-03-04
- 2025-12-31: Contractual Obligation, to be Paid, Year One 35.00K GBP.
GBP
| Period end | Contractual Obligation, to be Paid, Year One |
|---|---|
| 2025-12-31 | 35.00K GBP 10-K · filed 2026-03-04 |
USD
| Period end | Contractual Obligation, to be Paid, Year One |
|---|---|
| 2025-12-31 | $500.00K 10-K · filed 2026-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |